Bridgeway Capital Management’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $12.3K | Hold |
|
|||||
|
2023
Q3 | $15.4K | Hold |
|
|||||
|
2023
Q2 | $28.5K | Hold |
|
|||||
|
2023
Q1 | $19.9K | Hold |
|
|||||
|
2022
Q4 | $13K | Hold |
|
|||||
|
2022
Q3 | $28K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $20K | Hold |
|
|||||
|
2021
Q3 | $34K | Hold |
|
|||||
|
2021
Q2 | $45K | Sell |
|
|||||
|
2021
Q1 | $75K | Hold |
|
|||||
|
2020
Q4 | $42K | Hold |
|
|||||
|
2020
Q3 | $52K | Hold |
|
|||||
|
2020
Q2 | $56K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $228K | Sell |
|
|||||
|
2016
Q4 | $336K | Sell |
|
|||||
|
2016
Q3 | $769K | Sell |
|
|||||
|
2016
Q2 | $1.04M | Hold |
|
|||||
|
2016
Q1 | $1.37M | Buy |
|
|||||
|
2015
Q4 | $520K | Hold |
|
|||||
|
2015
Q3 | $516K | Buy |
|
|||||
|
2015
Q2 | $143K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $71K | Hold |
|
|||||
|
2014
Q2 | $69K | Hold |
|
|||||
|
2014
Q1 | $103K | Hold |
|
|||||
|
2013
Q4 | $61K | Sell |
|
|||||
|
2013
Q3 | $134K | Hold |
|
|||||
|
2013
Q2 | $138K | Buy |
|